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Poverty remains the overriding social determinant for the neglected tropical diseases (NTDs),
but over the last several decades, we have also seen how political destabilization or even out-
right conflict can hasten economic declines and promote a substantial uptick in NTD inci-
dence and prevalence [1]. Recent examples include the emergence of Ebola virus infection in
West Africa [2], visceral leishmaniasis and other NTDs in East Africa [3, 4], and cutaneous
leishmaniasis in the Middle East and North Africa [5], as well as guerilla activities linked to the
drug trade in Latin America [6]. Vector-borne (taken here to encompass diseases transmitted
by arthropods or snails) and zoonotic NTDs have been disproportionately represented among
these emerging or reemerging infections.
A recent example of vector-borne NTDs reemerging due to political destabilization and
economic collapse has been happening in Venezuela (Fig 1) [7–10].
The Bolivarian Republic of Venezuela has a population of approximately 31 million with a
geographic area of approximately 350,000 square miles, about 15% and 30% larger than Texas,
respectively. For decades, Venezuela was considered a leader in the areas of vector control and
public health policies in the Latin American region [8]. In fact, it is regarded as the first coun-
try to eradicate malaria in much of its territory after a successful insecticide-spraying campaign
led by Arnoldo Gabaldo´n in the 1950s [11]. However, investments both in healthcare infra-
structure and public health prevention efforts began to decrease during the regime of President
Hugo Chavez in the 2000s, with even steeper declines beginning in 2013 with President Nico-
las Maduro [8]. According to a recent report in The Guardian, Venezuela is currently suffering
an economic crisis of historical proportions with marked negative economic growth and high
rates of inflation and unemployment [12]. Food insecurity is rampant and there are serious
shortages of medicines and insecticides [8,12,13]. The detailed underlying basis of Venezuela’s
crisis is beyond the scope of this article, but among the major factors cited are the overreliance
on oil in the setting of a crash in oil prices, “reckless” public financing and printing of public
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money leading to an overvalued currency, massive debts and inflation, withdrawals in external
investments and donor support, and public corruption [12–14].
The political determinants of health inequity have been comprehensively reviewed by a
high-level Lancet–University of Oslo Commission on Global Governance for Health [15].
Although written before the current Venezuelan crisis, many of its findings and tenets, as
described below, are relevant to the current situation. Overall, the rise in Venezuela’s vec-
tor-borne NTDs can be attributed to a number of factors, including (1) shortages of insec-
ticides, antiparasitic medicines (e.g., antimalarials and drugs for leishmaniasis and Cha-
gas disease), and fuel, which hinder vector-control and disease-treatment efforts, (2)
underlying malnutrition due to food insecurity, (3) human migrations associated with
illegal mining, and (4) lapses in support for government health workers [8]. The added
depletion of the health system in Venezuela due to economic and political pressures has
also reduced epidemiological surveillance and reporting activities. Sadly, these determi-
nants are playing out in the setting of an already unprecedented rise of arbovirus infec-
tions currently emerging across the Americas, including dengue, chikungunya, and Zika
virus infections [1]. We have also seen widespread increases in Venezuela’s vector-borne
parasitic infections.
Fig 1. Venezuela. Original figure made by Prof. Maria Eugenia Grillet with ArcGis.
https://doi.org/10.1371/journal.pntd.0005423.g001
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Vector-borne protozoan infections
Malaria caused both by Plasmodium falciparum and P. vivax represents 1 of the most obvious
rises in Venezuela’s neglected diseases. It has been noted that highly malaria-endemic nations,
such as Brazil, Colombia, and, indeed, the Americas overall, have achieved a 50% or more
decrease in malaria cases [9] in pursuit of Millennium Development Goals and targets and as
part of their Global Fund to Fight AIDS, Tuberculosis, and Malaria objectives and targets as
they pertain specifically to the Global Malaria Action Plan 2008–2015.
In contrast, there has been almost a 3-fold increase in Venezuelan malaria cases since 2014.
According to the Pan American Health Organization–World Health Organization (PAHO--
WHO), there were 240,613 confirmed malaria cases in Venezuela in 2016 [16]. Among the fac-
tors fueling malaria’s rise have been illegal mining operations (especially gold mining) in the
southern part of the country, with an influx of migrant workers living in overcrowded and
unhealthful conditions [7, 8], together with overall shortages of essential antimalarial drugs
[9], in addition to the lapses in vector-control efforts highlighted above. However, it is also
possible that El Niño/La Niña–Southern Oscillations could simultaneously be fueling a com-
ponent of this uptick in both P. falciparum and P. vivax malaria cases [17, 18].
During the first decades of the 20th century, Venezuela experienced 1 of the worst malaria
death rates in the Americas, possibly even causing substantial population decreases [11]. Sub-
sequently, and as noted above, Venezuela pursued an aggressive program of malaria control
up until the 1970s, with dramatic decreases in malaria incidence [11]. While some gains are
continuing among some Amerindian communities in Venezuela [19], overall, there are con-
cerns that, left unchecked, an expansion in malaria cases and incidence could reverse many of
the 20th century gains in malaria control. For example, it is believed that the current Venezue-
lan epidemic is exporting cases to Brazil, Guyana, and Colombia and creating cross-border
issues with these countries. Malaria mortality will likely increase in Venezuela, which, accord-
ing to a public letter (“Carta Pu´blica”) written by 4 former health ministers, is suffering from
possibly its worst malaria epidemic in the last 75 years [20].
Leishmaniasis and Chagas disease are 2 other vector-borne protozoan infections of con-
cern. With regards to the former, there have also been shortages of antimony-containing antil-
eishmanial drugs [9]. While some leishmaniasis research is still continuing in the country [21,
22], our overall understanding is that it has been extremely challenging to conduct research
due to lack of funds and collapsed scientific infrastructure.
For Chagas disease in Venezuela, 1 of the most unusual recent features has been new urban
and peri-urban outbreaks of orally acquired and food-borne disease [23–29]. Fruit juices are a
common food source, especially juices contaminated with the vector Panstrongylus geniculatus
[29]. Among the factors associated with the rise in food-borne Chagas disease may be the
urbanization and deforestation of woodland areas contaminated with triatomines, the urbani-
zation of P. geniculatus, and the higher infectivity of Trypanosoma cruzi (and severity of dis-
ease) noted to occur via the oral route [29]. Food-borne Chagas disease is not restricted to
Venezuela, but it appears that the largest numbers of outbreaks are being reported from there.
Beyond food-borne transmission, there has also been a dramatic uptick in vector-transmit-
ted Chagas disease. In the decades prior to the 2000s and through active surveillance, house-
hold spraying with residual insecticides, and home improvement, dramatic reductions
occurred in the seroprevalence of human Chagas disease, including reductions in pediatric
seroprevalence, which confirmed the impact of public health control measures on interrupting
transmission [30, 31]. However, due to subsequent vector control and health system lapses
during the Chavez era, the vectoral transmission and disease incidence of Chagas disease
returned in both rural [32, 33] and urban areas, including Caracas [27].
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Ultimately, while there is an increased research focus in oral Chagas disease transmission in
Venezuela, there is also absence of political will to vigorously address this situation, despite
reports being regularly made available to local and national health authorities.
Intermediate host-borne and vector-borne helminth infections
Schistosomiasis and onchocerciasis represent 2 of the major helminth infections in Venezuela.
Venezuela, Brazil, Suriname, and Saint Lucia account for the last 4 nations in the Americas
with a significant level of transmission of intestinal schistosomiasis caused by Schistosoma
mansoni [34]. In Venezuela, most of the cases are found in the northern coastal part of the
country [34, 35]. Mass drug administration with praziquantel has had an impact on reducing
the prevalence in many endemic communities [36], but it is believed that, in some areas, there
has been an increase in schistosomiasis transmission due to depletion of surveillance and con-
trol activities [35], while urban foci of schistosomiasis may also remain [37].
Similarly, through mass drug administration with ivermectin beginning in 2000, interrup-
tion of onchocerciasis has been achieved among the northern foci located in the coastal moun-
tain area [38, 39]. However, a southern focus in the Amazon rainforest region remains, mostly
among the Yanomami indigenous groups [40]. This focus may represent 1 of the last major
river blindness endemic areas in the Americas [40]. It was reported in 2016 that significant
progress has been achieved recently in reducing transmission and effecting “morbidity sup-
pression” in 75% of the Yanomami populations in this region [40]. Thus, paradoxically, the
onchocerciasis elimination program in the Amazonian focus has continued to work reason-
ably well under the regional auspices and support of the Onchocerciasis Elimination Program
for the Americas (OEPA) and from the commitments and resolve of its local health workers
and managers [40].
Arbovirus infections
Dengue, chikungunya, and now Zika virus infections are on the rise in Venezuela. Aside from
lapses in vector control, other major factors include specific decreases in dengue government
funding and hoarding of stored water due to lack of regular access to clean and safe water sup-
plies [8, 41]. According to PAHO-WHO, the number of reported cases is still far below those
of other Latin American countries including Brazil, Colombia, and Paraguay [41], although
this finding may reflect a significant level of underreporting. Dengue remains an important
cause of illness and death among Venezuelan children [42], but patient knowledge about the
disease and health-seeking behavior is lacking [43]. It is believed that dengue fever was
exported from Venezuela to ignite a dengue outbreak in Madeira, Portugal, in 2012–2013 [44].
In 2014, chikungunya was introduced in Venezuela, where it has also emerged as an impor-
tant arbovirus infection with life-threatening and even fatal cases reported [45, 46]. Like den-
gue, the disease is probably vastly underreported—when it first entered the population, the
attack rate may have reached as high as 13.8% [46]. It is believed that Venezuela has fallen
behind in control efforts for these 2 arbovirus infections [47]. In addition, Venezuela now
hosts the third largest number of Zika cases in the Americas (behind Brazil and Colombia),
according PAHO-WHO [48], and the disease has become widespread in the country [49].
There are also concerns about the emergence or re-emergence of Mayaro virus [50] and Vene-
zuelan equine encephalitis [51].
Concluding comments
There continues to be progress in the reduction and control of Venezuela’s vector-borne hel-
minth infections, but the abrupt rise of malaria, leishmaniasis, Chagas disease, and arbovirus
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infections presents a concerning and troubling situation that may be reaching crisis propor-
tions, with spread of these diseases now occurring from Venezuela to adjacent countries. Fur-
ther adding to the Venezuelan crisis, there have been attacks and vandalism on the nation’s
scientists and institutions. For example, the Instituto de Medicina Tropical of the Universidad
Central de Venezuela, a leading center of excellence in the Americas, has suffered repeated epi-
sodes of vandalism, with destruction of scientific equipment, records, and samples, forcing it
to suspend operations. Our understanding is that this institution may not be the only one
affected in Venezuela.
The Lancet–University of Oslo Commission on Global Governance for Health points out
that health inequities such as those described must be addressed at the global level and not
only at the national level or only within the health sector [15]. For those reasons, we urge
regional leaders, possibly through the Organization of American States (OAS), together with
the major UN agencies (including PAHO-WHO) and international funding organizations, to
offer assistance in order to prevent a humanitarian catastrophe in the country, as well as one
that could expand across the tropical regions of the Americas. Over time, the leadership of
Venezuela will need to expand its efforts with the international community to restore labora-
tory and disease-surveillance capacity, while implementing disease-control efforts in programs
of health-system strengthening.
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